banner
Raf inhibitor AZ628, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ958

Raf inhibitor AZ628, Purity ≥98%

Synonym: 878739-06-1; AZ 628; AZ-628; AZ628; 3-(2-Cyanopropan-2-yl)-N-(4-methyl-3-((3-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)amino)phenyl)benzamide; 3-(2-Cyanopropan-2-yl)-N-(4-methyl-3-(3-methyl-4-oxo-3,4-dihydroquinazolin-6-ylamino)phenyl)benzamide; Raf inhibitor

  • MDL: MFCD17392577
  • CAS Number: 878739-06-1
  • Compound CID: 11676786
img
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
AZ628, soluble in DMSO and insoluble in ethanol and water, blocks a MAPK/ERK signaling pathway. It targets B-Raf, B-Raf (V600E), and C-Raf-1.
Molecular Weight
451.5
Molecular Formula
C27H25N5O2
Targets
B-Raf: 105 nM; B-Raf (V600E): 34 nM; C-Raf-1: 29 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 80 mg/mL (177.17 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
AZ628 can be applied to investigate BRAF and CRAF kinase activity in the MAPK signaling pathway.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0